Unknown

Dataset Information

0

BMP9 Promotes an Epithelial Phenotype and a Hepatocyte-like Gene Expression Profile in Adult Hepatic Progenitor Cells.


ABSTRACT: Bone morphogenetic protein 9 (BMP9), a member of the TGF-β superfamily, has emerged as a new player in chronic liver diseases (CLDs). Its levels increase in the fibrotic liver where it promotes fibrogenesis. It also regulates hepatic progenitor cells (oval cells in rodents), a cell population that contributes to repopulate the liver and recover functionality upon severe damage, but it can also be pro-fibrogenic, depending upon the hepatic microenvironment. Here we analyze the effect of chronic exposure to BMP9 in oval cells. We show that cells chronically treated with BMP9 (B9T-OC) display a more epithelial and hepatocyte-like phenotype while acquiring proliferative and survival advantages. Since our previous studies had revealed a functional crosstalk between BMP9 and the HGF/c-Met signaling pathways in oval cells, we analyzed a possible role for HGF/c-Met in BMP9-induced long-term effects. Data evidence that active c-Met signaling is necessary to obtain maximum effects in terms of BMP9-triggered hepatocytic differentiation potential, further supporting functionally relevant cooperation between these pathways. In conclusion, our work reveals a novel action of BMP9 in liver cells and helps elucidate the mechanisms that serve to increase oval cell regenerative potential, which could be therapeutically modulated in CLD.

SUBMITTER: Addante A 

PROVIDER: S-EPMC8834621 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

BMP9 Promotes an Epithelial Phenotype and a Hepatocyte-like Gene Expression Profile in Adult Hepatic Progenitor Cells.

Addante Annalisa A   González-Corralejo Carlos C   Roncero Cesáreo C   Lazcanoiturburu Nerea N   García-Sáez Juan J   Herrera Blanca B   Sánchez Aránzazu A  

Cells 20220121 3


Bone morphogenetic protein 9 (BMP9), a member of the TGF-β superfamily, has emerged as a new player in chronic liver diseases (CLDs). Its levels increase in the fibrotic liver where it promotes fibrogenesis. It also regulates hepatic progenitor cells (oval cells in rodents), a cell population that contributes to repopulate the liver and recover functionality upon severe damage, but it can also be pro-fibrogenic, depending upon the hepatic microenvironment. Here we analyze the effect of chronic e  ...[more]

Similar Datasets

| S-EPMC7140668 | biostudies-literature
| S-EPMC3225069 | biostudies-literature
| S-EPMC6831459 | biostudies-literature
| S-EPMC6771233 | biostudies-literature
| S-EPMC4216526 | biostudies-literature
| S-ECPF-GEOD-34440 | biostudies-other
| S-EPMC5389644 | biostudies-literature
| S-EPMC3171483 | biostudies-literature
| S-EPMC6496372 | biostudies-literature
| S-EPMC5154353 | biostudies-literature